Literature DB >> 1712714

Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.

A J Reyes1.   

Abstract

The effects of single oral doses of common formulations of diuretics (i.e. formulations on the market or designed to be marketed) on 24-hour diuresis and natriuresis in healthy subjects are considered as a measure of the renal excretory potency of diuretics. Common formulations of distal tubular diuretics (e.g. hydrochlorothiazide 25mg, xipamide 10mg and 20mg) are more potent diuretics and natriuretics than common formulations of loop diuretics [e.g. furosemide (frusemide) 40mg, torasemide 2.5, 5 and 10mg]. Indeed, some common formulations of loop diuretics, such as torasemide 2.5, do not increase 24-hour diuresis or natriuresis in healthy subjects. 24-hour kaliuresis and magnesiuresis are elevated by common formulations of distal tubular diuretics, but they are only slightly increased or (more usually) not affected by common formulations of loop diuretics, when single doses are administered to healthy individuals. Common formulations of loop diuretics have lower diuretic and natriuretic potency and lower kaliuretic and magnesiuretic effects than common formulations of distal tubular diuretics, because the pronounced elevations in urinary excretions caused by loop diuretics during the first 6 hours after dosing are followed by rebounds, with respect to post-placebo excretions, between 6 and 24 hours after dosing. These rebounds, which affect the urinary flows of fluid, chloride, sodium, potassium and magnesium, do not occur after administration of common formulations of distal tubular diuretics, at least during the first 24 hours after administration of single doses to healthy subjects. The time courses of urinary excretions after loop diuretics are dose dependent. Higher doses produce more rapid changes in the urinary flows of fluid, chloride, sodium, potassium and magnesium than lower doses, to the extent that single administration of torasemide 2.5 or 5mg to healthy subjects is followed by urinary fluid and solute flows whose time courses resemble those after administration of hydrochlorothiazide 25mg.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712714     DOI: 10.2165/00003495-199100413-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

1.  Scientific vs. statistical inference: the problem of multiple contrasts in clinical research.

Authors:  K J Ottenbacher
Journal:  Am J Med Sci       Date:  1988-03       Impact factor: 2.378

2.  The insignificance of a probability value of p less than 0.05 in the evaluation of medical scientific studies.

Authors:  P E Romano
Journal:  J Lab Clin Med       Date:  1988-05

3.  Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.

Authors:  W P Leary; A J Reyes; R D Wynne; K van der Byl
Journal:  J Int Med Res       Date:  1990 Mar-Apr       Impact factor: 1.671

Review 4.  Clinical pharmacologic implications in diuretic selection.

Authors:  J B Puschett
Journal:  Am J Cardiol       Date:  1986-01-24       Impact factor: 2.778

Review 5.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

6.  Diuretics.

Authors:  W P Leary; A J Reyes
Journal:  S Afr Med J       Date:  1981-01-03

Review 7.  Diuretics in cardiovascular therapy. Perusing the past, practising in the present, preparing for the future.

Authors:  S H Taylor
Journal:  Z Kardiol       Date:  1985

8.  Factors affecting potassium balance during frusemide administration.

Authors:  C S Wilcox; W E Mitch; R A Kelly; P A Friedman; P F Souney; C M Rayment; T W Meyer; K L Skorecki
Journal:  Clin Sci (Lond)       Date:  1984-08       Impact factor: 6.124

9.  Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.

Authors:  J Delarge
Journal:  Arzneimittelforschung       Date:  1988-01

Review 10.  Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B N Prichard; R N Brogden
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

View more
  11 in total

Review 1.  An unexpected journey: conceptual evolution of mechanoregulated potassium transport in the distal nephron.

Authors:  Rolando Carrisoza-Gaytan; Marcelo D Carattino; Thomas R Kleyman; Lisa M Satlin
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-02       Impact factor: 4.249

2.  Role of NKCC in BK channel-mediated net K⁺ secretion in the CCD.

Authors:  Wen Liu; Carlos Schreck; Richard A Coleman; James B Wade; Yubelka Hernandez; Beth Zavilowitz; Richard Warth; Thomas R Kleyman; Lisa M Satlin
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-03

3.  Gender differences in adherence to the sodium-restricted diet in patients with heart failure.

Authors:  Misook L Chung; Debra K Moser; Terry A Lennie; Linda Worrall-Carter; Brooke Bentley; Robin Trupp; Deborah S Armentano
Journal:  J Card Fail       Date:  2006-10       Impact factor: 5.712

Review 4.  Sensing of tubular flow and renal electrolyte transport.

Authors:  Eric H J Verschuren; Charlotte Castenmiller; Dorien J M Peters; Francisco J Arjona; René J M Bindels; Joost G J Hoenderop
Journal:  Nat Rev Nephrol       Date:  2020-03-03       Impact factor: 28.314

Review 5.  Clinicopharmacological reappraisal of the potency of diuretics.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 6.  Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 7.  Do diuretics cause magnesium deficiency?

Authors:  D L Davies; R Fraser
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 8.  Which diuretic to use?

Authors:  C R Swanepoel
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Furosemide reduces BK-αβ4-mediated K+ secretion in mice on an alkaline high-K+ diet.

Authors:  Bangchen Wang; Jun Wang-France; Huaqing Li; Steven C Sansom
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-28

Review 10.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.